Sen. Menendez, Pascrell Call on FDA to Stop Promoting Unproven COVID-19 Treatments That Could Endanger Patients
April 09, 2020
April 09, 2020
NEWARK, New Jersey, April 9 -- Sen. Robert Menendez, D-New Jersey, issued the following news release:
U.S. Senator Bob Menendez and Bill Pascrell, Jr. (N.J.-09) called on the U.S. Food and Drug Administration (FDA) to grant approvals for therapeutics to combat COVID-19 based on science, not politics or political interference. The FDA recently granted Emergency Use Authorization (EUA) to two products, hydroxycholoroquine and CYNK-001, without sufficient scientific evidence of its val . . .
U.S. Senator Bob Menendez and Bill Pascrell, Jr. (N.J.-09) called on the U.S. Food and Drug Administration (FDA) to grant approvals for therapeutics to combat COVID-19 based on science, not politics or political interference. The FDA recently granted Emergency Use Authorization (EUA) to two products, hydroxycholoroquine and CYNK-001, without sufficient scientific evidence of its val . . .